Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.

Current theories suggest that atherosclerosis, plaque rupture, stroke, and restenosis after angioplasty may involve defective apoptotic mechanisms in vascular cells. Prior work has demonstrated that cells from human atherosclerotic lesions, and cells from the aorta of aged rats, exhibit functional resistance to apoptosis induced by TGF-beta and glucocorticoids. The present studies demonstrate that human lesion-derived cells (LDC) are also resistant to apoptosis induced by fas ligation compared to cells derived from the adjacent media, and that in vitro expansion of LDC causes acquired resistance to apoptosis. Microarray profiling of fas-resistant versus sensitive cells identified a set of genes including STATs, caspase 1, cyclin D1, Bcl-xL, VDAC2, and BAD. The STAT proteins have been implicated in resistance to apoptosis, potentially via their ability to modulate caspase 1 (ICE), Bcl-xL, and cyclin D1 expression. Western blot analysis of sensitive and resistant LDC clonal lines confirmed increases in cyclin D1, STAT6, Bcl-xL, and BAD, with decreased expression of caspase 1. Thus, transcript profiling has identified a potential pathway of apoptotic regulation in subsets of lesion cells. The resistant phenotype may contribute to plaque stability and excessive vascular repair, while sensitive cells may be involved in plaque rupture and infarction. The data suggests both genetic interventions and novel small-molecule inhibitors that may be effective modulators of apoptosis in atherosclerosis, angina, and in-stent restenosis.

[1]  S. Korsmeyer,et al.  VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.

[2]  Y Ikawa,et al.  Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Latchman,et al.  Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters , 2000, Cell Death and Differentiation.

[4]  J. Darnell,et al.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. DuBois,et al.  Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. , 1997, Cancer research.

[6]  Cindy L. Kanies,et al.  Protein Phosphatase 2A Dephosphorylation of Phosphoserine 112 Plays the Gatekeeper Role for BAD-Mediated Apoptosis , 2003, Molecular and Cellular Biology.

[7]  Stanley N Cohen,et al.  Smurf2 up-regulation activates telomere-dependent senescence. , 2004, Genes & development.

[8]  Cheorl-Ho Kim,et al.  In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells. , 2003, Archives of biochemistry and biophysics.

[9]  S. Korsmeyer,et al.  BAD Is a Pro-survival Factor Prior to Activation of Its Pro-apoptotic Function* , 2004, Journal of Biological Chemistry.

[10]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[11]  B. Berk,et al.  Big Mitogen-Activated Protein Kinase (BMK1)/ERK5 Protects Endothelial Cells From Apoptosis , 2004, Circulation research.

[12]  T. McCaffrey,et al.  Glucocorticoid resistance caused by reduced expression of the glucocorticoid receptor in cells from human vascular lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Kent,et al.  Elevated Egr-1 in Human Atherosclerotic Cells Transcriptionally Represses the Transforming Growth Factor-β Type II Receptor* , 2000, The Journal of Biological Chemistry.

[14]  V. Fadok,et al.  Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. , 2002, The Journal of clinical investigation.

[15]  Ronald D.G. McKay,et al.  BMPs signal alternately through a SMAD or FRAP–STAT pathway to regulate fate choice in CNS stem cells , 2003, The Journal of cell biology.

[16]  Drug‐eluting stents for the prevention of restenosis: Standing the test of time , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  T. Collins,et al.  The SCAN domain defines a large family of zinc finger transcription factors. , 2003, Gene.

[18]  B. Calabretta,et al.  Transforming Growth Factor 1 Induces Apoptosis through Cleavage of BAD in a Smad3-Dependent Mechanism in FaO Hepatoma Cells , 2002 .

[19]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[20]  T. McCaffrey,et al.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1. , 1995, The Journal of clinical investigation.

[21]  R. Day,et al.  Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. , 1990, Cancer research.

[22]  Richard J. Lee,et al.  Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis* , 1999, The Journal of Biological Chemistry.

[23]  M. White,et al.  Interleukin-4-mediated Protection of Primary B Cells from Apoptosis through Stat6-dependent Up-regulation of Bcl-xL* , 2002, The Journal of Biological Chemistry.

[24]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[25]  F. Neumann,et al.  Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. , 2001, Molecular cell.

[26]  R. Weinberg,et al.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase , 1998, Oncogene.

[27]  F. Tang,et al.  Cellular growth inhibition by IGFBP‐3 and TGF‐β1 requires LRP‐1 , 2003 .

[28]  J. Weitzman,et al.  JunD protects cells from p53-dependent senescence and apoptosis. , 2000, Molecular cell.

[29]  I. Weinstein,et al.  Roles of Specific Isoforms of Protein Kinase C in the Transcriptional Control of Cyclin D1 and Related Genes* , 2003, Journal of Biological Chemistry.

[30]  S. Desrivières,et al.  Rapamycin Inhibition of the G1 to S Transition Is Mediated by Effects on Cyclin D1 mRNA and Protein Stability* , 1998, The Journal of Biological Chemistry.

[31]  C. Thompson,et al.  Elevated expression of Bcl-2 and Bcl-x by intestinal intraepithelial lymphocytes: resistance to apoptosis by glucocorticoids and irradiation. , 1997, International immunology.

[32]  P. Mahrer,et al.  Spontaneous regression of restenosis: an angiographic study. , 1995, Journal of the American College of Cardiology.

[33]  M. Bennett,et al.  Human Blood-Derived Macrophages Induce Apoptosis in Human Plaque-Derived Vascular Smooth Muscle Cells by Fas-Ligand/Fas Interactions , 2001 .

[34]  Xia Lin,et al.  Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210 , 2000, The Journal of Biological Chemistry.

[35]  G. Semenza,et al.  Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity* , 2000, The Journal of Biological Chemistry.

[36]  J. Leiden,et al.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. , 1995, The Journal of clinical investigation.

[37]  S. R. Datta,et al.  Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. , 2002, Developmental cell.

[38]  J. Mountz,et al.  The Prodomain of Caspase-1 Enhances Fas-mediated Apoptosis through Facilitation of Caspase-8 Activation* , 2000, The Journal of Biological Chemistry.

[39]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Flavell,et al.  Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis , 1997, Molecular and cellular biology.

[41]  A. Okamoto,et al.  Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Littlewood,et al.  Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. , 1997, Circulation research.

[43]  P. Serruys,et al.  No delayed restenosis at 18 months after implantation of sirolimus‐eluting stent , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[44]  G. Evan,et al.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. , 1995, The Journal of clinical investigation.

[45]  A. Desmoulière,et al.  Apoptosis participates in cellularity regulation during rat aortic intimal thickening. , 1995, The American journal of pathology.

[46]  T. Ohta,et al.  In vitro ubiquitination of cyclin D1 by ROC1–CUL1 and ROC1–CUL3 , 2001, FEBS letters.

[47]  M. David,et al.  Preassociation of STAT1 with STAT2 and STAT3 in Separate Signalling Complexes Prior to Cytokine Stimulation (*) , 1996, The Journal of Biological Chemistry.

[48]  S. Oyadomari,et al.  hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria , 2004, Cell Death and Differentiation.

[49]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[50]  J. Darnell,et al.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  L. Ellis,et al.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis , 2002, Oncogene.

[52]  P. Stambrook,et al.  Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. , 2001, Molecular biology of the cell.

[53]  S. Thorgeirsson,et al.  In vivo expression and genomic organization of the mouse cyclin I gene (Ccni). , 2000, Gene.

[54]  C. Thompson,et al.  Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  K. Walsh,et al.  Vascular cell apoptosis in remodeling, restenosis, and plaque rupture. , 2000, Circulation research.

[56]  R. Flavell,et al.  Disruption of TGF-β signaling in T cells accelerates atherosclerosis , 2003 .

[57]  A. Rebollo,et al.  Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis. , 2003, Biochimie.

[58]  B. Lüderitz,et al.  Apoptosis in restenosis versus stable-angina atherosclerosis: implications for the pathogenesis of restenosis. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[59]  A. Inoue,et al.  Failure To Proliferate and Mitotic Arrest of CDK11p110/p58-Null Mutant Mice at the Blastocyst Stage of Embryonic Cell Development , 2004, Molecular and Cellular Biology.

[60]  J. Dumont,et al.  Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat. , 1999, Circulation.

[61]  E. Nabel,et al.  Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[62]  M. Bennett,et al.  Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells. , 2000, Circulation research.

[63]  B. Schreiber,et al.  β-Migrating Very Low Density Lipoprotein (βVLDL) Activates Smooth Muscle Cell Mitogen-activated Protein (MAP) Kinase via G Protein-coupled Receptor-mediated Transactivation of the Epidermal Growth Factor (EGF) Receptor , 2001, The Journal of Biological Chemistry.

[64]  B. Björkerud,et al.  Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. , 1996, The American journal of pathology.

[65]  G. Boltz‐Nitulescu,et al.  Increased serum concentrations of soluble CD95/Fas and caspase 1/ICE in patients with acute angina , 2004, Heart.

[66]  M. Tyers,et al.  Osprey: a network visualization system , 2003, Genome Biology.

[67]  T. McCaffrey,et al.  The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. , 1999, Journal of molecular and cellular cardiology.

[68]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[69]  D. Falcone,et al.  Fibronectin Stimulates Macrophage Uptake of Low Density Lipoprotein‐Heparin‐Collagen Complexes , 1988, Arteriosclerosis.

[70]  J. O’Rourke,et al.  Signal Transducer and Activator of Transcription 3 Activates CCAAT Enhancer-binding Protein δ Gene Transcription in G0Growth-arrested Mouse Mammary Epithelial Cells and in Involuting Mouse Mammary Gland* , 2000, The Journal of Biological Chemistry.

[71]  P. Libby,et al.  Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.